The French National Institute of Health and Medical Research (INSERM) and Sociology and Economics of Networks and Services lab at Orange Experience Design Lab published a RECOVER co-funded paper on the impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies.

In the early months of 2020, a novel COVID-19 spread rapidly from China across multiple countries worldwide. As of March 17, 2020, COVID-19 was officially declared a pandemic by the World Health Organization. We collected data on COVID-19 cases outside China during the early phase of the pandemic and used them to predict trends in importations and quantify the proportion of undetected imported cases.

RECOVER project team published an article in Eurosurveilance presenting results of a first external quality assessment (EQA) on molecular detection of SARS-CoV-2, as well as data from a RECOVER survey assessing the molecular testing capacity and throughput of clinical laboratories in 36 countries.

Even as the lockdown is beginning to lift across the EU, public health measures COVID19 pandemic impact nearly every aspect of everyday life. Risk communication efforts are needed to explain the government advice and address the uncertainties of the population.

Understanding the kinetics of infectious virus shedding in relation to potential for transmission is crucial to guide infection prevention and control strategies. We assessed these questions using virus cultures of respiratory tract samples from hospitalized COVID-19 patients as a proxy for infectious virus shedding.

The home environment is a complex context for the care of sick and vulnerable people. A recent commentary in the Lancet, co-authored by a social scientist in the RECOVER consortium, draws attention to the challenges faced by those providing care in the home.

The research teams of INSERM and Orange Lab published a RECOVER-funded preprint paper population mobility reductions during COVID-19 epidemic in France under lockdown (Pullano et al. 2020). The study findings help predicting how and where restrictions will be the most effective in reducing the mobility and mixing of the population, thus aiding tuning recommendations when phasing out lockdown.

On Wednesday 13 May 2020, the Global Health Network hosted a webinar entitled ‘REMAP-CAP and Why we need Platform Trials in a Pandemic’. The goal of the webinar was to introduce REMAP-CAP and the concept of adaptive platform trials more broadly, as well as discuss the upsides and challenges of such trials in a pandemic.

15 May 2020

We are inviting European healthcare workers that currently provide hospital care (both COVID-19 related and non-COVID-19-related), to participate in a 10-min online survey.

RECOVER’s Clinical Biological Study team has published a preprint paper identifying several early independent SARS-CoV-2 introductions without local transmission, highlighting the efficacy of the measures taken in France to prevent virus spread from symptomatic cases.